Athersys
ATHX
#11214
Rank
NZ$1.44 M
Marketcap
NZ$0.02348
Share price
-33.50%
Change (1 day)
-98.86%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -NZ$67.38 Million

According to Athersys's latest financial reports the company's current earnings are NZ$0.08 Million. In 2022 the company made an earning of -NZ$0.14 Billion, an increase over its 2021 earnings that were of -NZ$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$67.38 Million-49.7%
2022 -NZ$0.14 Billion-11.54%
2021 -NZ$0.16 Billion11.14%
2020 -NZ$0.14 Billion72.2%
2019 -NZ$79.12 Million77.29%
2018 -NZ$44.63 Million-22.91%
2017 -NZ$57.89 Million111.89%
2016 -NZ$27.33 Million-8.52%
2015 -NZ$29.87 Million-40.81%
2014 -NZ$50.47 Million18.62%
2013 -NZ$42.54 Million
2011 -NZ$23.97 Million19.71%
2010 -NZ$20.03 Million-26.28%
2009 -NZ$27.16 Million-18.21%
2008 -NZ$33.21 Million-8.28%
2007 -NZ$36.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.18 B-62,307.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.42 B-25,460.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.80 B-21,859.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.32 B-18,438.39%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$22.87 B-31,592.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.69 B-23,080.22%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
NZ$0.29 B-499.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-NZ$5.42 Billion 7,351.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-NZ$1.1 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA